Global Dry Age-Related Macular Degeneration Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ1028463 No. of Pages: 133 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Dry Age-Related Macular Degeneration market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.
This report studies the Dry Age-Related Macular Degeneration market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Dry Age-Related Macular Degeneration in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Oral
Injectables
Market Snapshot, By Application
Above 40 Years
Above 60 Years
Above 75 Years
Main Market Players Analyzed in this report, including:
Y2 Solution
Stealth Biotherapeutics
Santen Pharmaceuticals
Phio Pharmaceuticals
Ocumension Therapeutics
Kubota Vision
Iveric Bio
Eyestem Research
Belite Bio
Bausch Health
Allergan
Alimera Science
The study objectives of this report are:
To study and analyze the global Dry Age-Related Macular Degeneration market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Dry Age-Related Macular Degeneration market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Dry Age-Related Macular Degeneration manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dry Age-Related Macular Degeneration market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Dry Age-Related Macular Degeneration submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Dry Age-Related Macular Degeneration are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Dry Age-Related Macular Degeneration Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Dry Age-Related Macular Degeneration Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Dry Age-Related Macular Degeneration
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Dry Age-Related Macular Degeneration Sales Channel and Distributors Analysis
3.3.1 Dry Age-Related Macular Degeneration Sales Channel
3.3.2 Dry Age-Related Macular Degeneration Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Above 40 Years
3.4.2 Major Buyers in Above 60 Years
3.5 Dry Age-Related Macular Degeneration Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Dry Age-Related Macular Degeneration Type Introduction
4.1.1 Oral
4.1.2 Injectables
4.2 Global Dry Age-Related Macular Degeneration Sales by Type 2016-2021
4.3 Global Dry Age-Related Macular Degeneration Revenue by Type 2016-2021
4.4 Global Dry Age-Related Macular Degeneration Price by Type 2016-2021
5 Market Segment: by Application
5.1 Dry Age-Related Macular Degeneration Type Introduction
5.1.1 Above 40 Years
5.1.2 Above 60 Years
5.1.3 Above 75 Years
5.2 Global Dry Age-Related Macular Degeneration Sales by Application 2016-2021
5.3 Global Dry Age-Related Macular Degeneration Revenue by Application 2016-2021
5.4 Global Dry Age-Related Macular Degeneration Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Dry Age-Related Macular Degeneration Market by Region
6.1.1 Global Dry Age-Related Macular Degeneration Sales by Regions
6.1.2 Global Dry Age-Related Macular Degeneration Revenue by Regions
6.2 North America Dry Age-Related Macular Degeneration Market 2016-2021
6.3 Europe Dry Age-Related Macular Degeneration Market 2016-2021
6.4 Asia Pacific Dry Age-Related Macular Degeneration Market 2016-2021
6.5 South America Dry Age-Related Macular Degeneration Market 2016-2021
6.6 Middle East and Africa Dry Age-Related Macular Degeneration Market 2016-2021
7 North America
7.1 North America Dry Age-Related Macular Degeneration Market by Country 2016-2021
7.1.1 North America Dry Age-Related Macular Degeneration Sales by Country
7.1.2 North America Dry Age-Related Macular Degeneration Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Dry Age-Related Macular Degeneration Market by Country 2016-2021
8.1.1 Europe Dry Age-Related Macular Degeneration Sales by Country
8.1.2 Europe Dry Age-Related Macular Degeneration Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Dry Age-Related Macular Degeneration Market by Country 2016-2021
9.1.1 Asia Pacific Dry Age-Related Macular Degeneration Sales by Country
9.1.2 Asia Pacific Dry Age-Related Macular Degeneration Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Dry Age-Related Macular Degeneration Market by Country 2016-2021
10.1.1 South America Dry Age-Related Macular Degeneration Sales by Country
10.1.2 South America Dry Age-Related Macular Degeneration Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Dry Age-Related Macular Degeneration Market by Country 2016-2021
11.1.1 Middle East and Africa Dry Age-Related Macular Degeneration Sales by Country
11.1.2 Middle East and Africa Dry Age-Related Macular Degeneration Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Y2 Solution
12.1.1 Y2 Solution
Company Information
12.1.2 Y2 Solution
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.1.3 Y2 Solution
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Y2 Solution
Key Development
12.2 Stealth Biotherapeutics
12.2.1 Stealth Biotherapeutics
Company Information
12.2.2 Stealth Biotherapeutics
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.2.3 Stealth Biotherapeutics
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Stealth Biotherapeutics
Key Development
12.3 Santen Pharmaceuticals
12.3.1 Santen Pharmaceuticals
Company Information
12.3.2 Santen Pharmaceuticals
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.3.3 Santen Pharmaceuticals
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Santen Pharmaceuticals
Key Development
12.4 Phio Pharmaceuticals
12.4.1 Phio Pharmaceuticals
Company Information
12.4.2 Phio Pharmaceuticals
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.4.3 Phio Pharmaceuticals
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Phio Pharmaceuticals
Key Development
12.5 Ocumension Therapeutics
12.5.1 Ocumension Therapeutics
Company Information
12.5.2 Ocumension Therapeutics
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.5.3 Ocumension Therapeutics
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Ocumension Therapeutics
Key Development
12.6 Kubota Vision
12.6.1 Kubota Vision
Company Information
12.6.2 Kubota Vision
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.6.3 Kubota Vision
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Kubota Vision
Key Development
12.7 Iveric Bio
12.7.1 Iveric Bio
Company Information
12.7.2 Iveric Bio
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.7.3 Iveric Bio
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Kubota Vision
Key Development
12.9 Belite Bio
12.9.1 Belite Bio
Company Information
12.9.2 Belite Bio
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.9.3 Belite Bio
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Belite Bio
Key Development
12.8 Eyestem Research
12.8.1 Eyestem Research
Company Information
12.8.2 Eyestem Research
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.8.3 Eyestem Research
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Eyestem Research
Key Development
12.11 Allergan
12.11.1 Allergan
Company Information
12.11.2 Allergan
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.11.3 Allergan
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Allergan
Key Development
12.12 Alimera Science
12.12.1 Alimera Science
Company Information
12.12.2 Alimera Science
Dry Age-Related Macular Degeneration Product Portfolio, Specification and Application
12.12.3 Alimera Science
Dry Age-Related Macular Degeneration Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Alimera Science
Key Development
13 Global Dry Age-Related Macular Degeneration Market Forecast by Region by Type and by Application
13.1 Global Dry Age-Related Macular Degeneration Sales, Revenue Forecast 2022-2027
13.2 Global Dry Age-Related Macular Degeneration Forecast by Regions
13.2.1 Global Dry Age-Related Macular Degeneration Sales Forecast by Region 2022-2027
13.2.2 Global Dry Age-Related Macular Degeneration Revenue Forecast by Region 2022-2027
13.3 Global Dry Age-Related Macular Degeneration Forecast by Type
13.3.1 Global Dry Age-Related Macular Degeneration Sales Forecast by Type 2022-2027
13.3.2 Global Dry Age-Related Macular Degeneration Revenue Forecast by Type 2022-2027
13.3.3 Global Dry Age-Related Macular Degeneration Price Forecast by Type 2022-2027
13.4 Global Dry Age-Related Macular Degeneration Forecast by Application
13.4.1 Global Dry Age-Related Macular Degeneration Sales Forecast by Application 2022-2027
13.4.2 Global Dry Age-Related Macular Degeneration Revenue Forecast by Application 2022-2027
13.4.3 Global Dry Age-Related Macular Degeneration Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com